Ennismore vs a2z Radiology AI

Side-by-side comparison of AI visibility scores, market position, and capabilities

Ennismore

LeaderTravel & Hospitality

Lifestyle Hotel Group

World's fastest-growing lifestyle hotel company; majority-owned by Accor. 16 brands, 190+ hotels, 500+ restaurants. Opened 20+ new hotels in 2025.

About

Ennismore is a hospitality company focused on lifestyle and design-led hotels, founded by Sharan Pasricha and majority-acquired by Accor in 2021 through a joint venture that merged Ennismore's original brands with Accor's lifestyle portfolio. Headquartered in London, Ennismore manages 16 distinct hotel brands—including The Hoxton, SLS Hotels, Mondrian, 25hours Hotels, Mama Shelter, Hyde, Gleneagles, Tribe, and Jo&Joe—across 190+ operating hotels and 145+ in the development pipeline. The company also operates over 500 branded restaurants and bars globally.\n\nEnnismore's operating model combines creative brand stewardship with centralized operational infrastructure. Each brand retains a distinct identity and design language, while Ennismore provides shared services in technology, procurement, loyalty (ALL - Accor Live Limitless), and revenue management. The group targets the growing "experience economy" traveler who prioritizes culture, F&B, and design over traditional hotel amenities.\n\nIn 2025, Ennismore opened over 20 new hotels and 35 new restaurant and bar destinations, entering new markets including Australia (Hyde, Mondrian, 25hours) and Ireland (The Hoxton Dublin). Launches in 2025 also included the Paris Society Hotel Collection, a curated portfolio of iconic European destination properties. Ennismore's pipeline reflects strong developer demand for lifestyle brands in the upper-midscale and upscale segments.

Full profile

a2z Radiology AI

EmergingEnterprise AI

Medical Imaging AI

a2z Radiology AI raised $20M in 2025 for its whole-body AI that simultaneously screens for 24+ conditions across CT scans — from incidental cancers to cardiovascular risk — in a single automated read.

About

a2z Radiology AI has developed a whole-body CT analysis platform that simultaneously screens for over 24 medical conditions across a single CT scan, including incidental cancers, coronary artery disease, aortic aneurysm, bone density loss, and organ abnormalities. The AI acts as a second reader that radiologists can use to catch incidental findings that fall outside the primary reason for a scan — a major source of missed diagnoses.

Full profile

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.